# IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma

> **NCT03795610** · PHASE2 · COMPLETED · sponsor: **Assuntina G. Sacco, MD** · enrollment: 16 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer
- Head and Neck Carcinoma
- Head and Neck Cancer Stage IV
- Head and Neck Cancer Stage III
- HPV-Related Carcinoma
- HPV-Related Malignancy
- HPV-Related Squamous Cell Carcinoma

## Interventions

- **DRUG:** IPI-549

## Key facts

- **NCT ID:** NCT03795610
- **Lead sponsor:** Assuntina G. Sacco, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-06
- **Primary completion:** 2022-12-22
- **Final completion:** 2023-08-24
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03795610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03795610, "IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03795610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*